JDOC ETF
JPMorgan Healthcare Leaders ETF
ABBV is JDOC's largest holding at 8.20% of the fund as of Oct 1, 2026. JDOC is JPMorgan Healthcare Leaders ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | A | AbbVie Inc.Health Care · Pharmaceuticals | 8.20% | 8.2% | 2,858 | $747.6K | Health Care | Pharmaceuticals |
| 2 | L | Eli Lilly & Co.Health Care · Pharmaceuticals | 7.78% | 16.0% | 613 | $709.3K | Health Care | Pharmaceuticals |
| Sector and industry · Pro | ||||||||
| 3 | M | Merck & Company Inc | 4.96% | 20.9% | 3,111 | $452.1K | ||
| 4 | J | Johnson & Johnson - | 4.85% | 25.8% | 1,672 | $442.6K | ||
| 5 | T | Thermo Fisherscientific Inc. | 4.60% | 30.4% | 622 | $419.9K | ||
| 6 | N | Novartis Ag - | 4.06% | 34.5% | 2,597 | $370.3K | ||
| 7 | — | AstraZeneca PLC | 3.95% | 38.4% | 2,233 | $360.6K | ||
| 8 | U | Unitedhealth Group Inc | 3.51% | 41.9% | 871 | $319.7K | ||
| 9 | — | Abbot Laboratories | 2.89% | 44.8% | 2,669 | $263.8K | ||
| 10 | D | Danaher Corp | 2.72% | 47.5% | 1,120 | $248.1K | ||
| 11 | — | Argenx | 2.63% | 50.2% | 250 | $239.8K | ||
| 12 | B | Bristol-Myers Squibb Co. | 2.60% | 52.8% | 3,798 | $237.0K | ||
| 13 | N | Novo Nordisk Class B | 2.50% | 55.3% | 6,019 | $227.9K | ||
| 14 | I | I Q V I A Holdings Inc. | 2.29% | 57.5% | 777 | $208.9K | ||
| 15 | C | Cvs Health Corp | 2.14% | 59.7% | 2,274 | $194.9K | ||
| 16 | C | Cencora Inc | 1.99% | 61.7% | 604 | $181.4K | ||
| 17 | — | Humm Group Ltd | 1.85% | 63.5% | 441 | $168.3K | ||
| 18 | T | Takeda Pharmaceutical Co. Ltd. Com Stk | 1.85% | 65.4% | 4,600 | $168.3K | ||
| 19 | B | Biogen Inc. | 1.84% | 67.2% | 743 | $167.8K | ||
| 20 | R | Regeneron Pharmaceuticals, Inc. | 1.77% | 69.0% | 213 | $161.5K | ||
| 21 | E | Edwards Lifesciences Corp | 1.73% | 70.7% | 1,827 | $157.7K | ||
| 22 | — | Roche Ps Par Ag | 1.72% | 72.4% | 377 | $156.7K | ||
| 23 | B | Bayer Ag | 1.60% | 74.0% | 2,707 | $146.1K | ||
| 24 | — | Teva Pharmaceutical Industries Ltd. | 1.50% | 75.5% | 3,445 | $136.8K | ||
| 25 | — | Nvaesrtex Pharmaceuticals Inc | 1.49% | 77.0% | 260 | $135.9K | ||
| 26 | I | Insmed Inc | 1.41% | 78.4% | 1,125 | $128.4K | ||
| 27 | — | Hoya Corp | 1.31% | 79.7% | 800 | $119.9K | ||
| 28 | C | Cardinal Health Inc. | 1.27% | 81.0% | 521 | $115.9K | ||
| 29 | S | Sandoz Group Ag | 1.25% | 82.3% | 1,359 | $114.3K | ||
| 30 | C | Charles River Laboratories International Inc | 1.18% | 83.4% | 364 | $107.4K | ||
| 31 | G | Genmab A/S | 1.02% | 84.5% | 263 | $93.0K | ||
| 32 | F | Fresenius Se & Co. Kgaa Germany | 1.01% | 85.5% | 1,831 | $92.3K | ||
| 33 | A | Alnylam Pharmaceuticals Inc. | 0.95% | 86.4% | 351 | $86.6K | ||
| 34 | N | Neurocrine Biosciences Inc | 0.84% | 87.3% | 540 | $76.6K | ||
| 35 | C | Centene | 0.81% | 88.1% | 1,194 | $74.2K | ||
| 36 | I | Intuitive Surgical Inc. | 0.78% | 88.9% | 175 | $71.2K | ||
| 37 | B | Biomarin Pharmaceutical Inc. | 0.67% | 89.5% | 1,024 | $61.4K | ||
| 38 | M | JPMorgan U.S. Government Money Market Fund, Class IM | 0.62% | 90.1% | 56,899 | $56.9K | ||
| 39 | S | Spyre Therapeutics Inc | 0.59% | 90.7% | 604 | $53.8K | ||
| 40 | B | Bridgebio Pharma Inc_None_0 | 0.59% | 91.3% | 822 | $54.1K | ||
| 41 | M | Medtronic Plc Ordinary Shares | 0.59% | 91.9% | 622 | $53.7K | ||
| 42 | C | Convatec Group Plc | 0.57% | 92.5% | 18,179 | $52.0K | ||
| 43 | P | Ptc Therapeutics Inc | 0.56% | 93.0% | 790 | $51.2K | ||
| 44 | — | Ascendis Pharma A/S | 0.54% | 93.6% | 218 | $49.7K | ||
| 45 | B | Boston Scientific Corp. | 0.53% | 94.1% | 1,112 | $48.5K | ||
| 46 | — | Dynegy | 0.52% | 94.6% | 2,968 | $47.8K | ||
| 47 | — | Sartorius Ag Pref | 0.51% | 95.1% | 160 | $46.5K | ||
| 48 | — | Gsk Plc Common Stock Gbp | 0.51% | 95.7% | 1,932 | $46.6K | ||
| 49 | — | Cash | 0.50% | 96.2% | 45,320 | $45.3K | ||
| 50 | L | Lb Pharmaceuticals Inc. | 0.45% | 96.6% | 1,059 | $40.6K | ||
| More holdings · Pro | ||||||||
JDOC ETF All Holdings
JDOC holdings total 64 positions. The top 10 holdings account for 47.5% of the fund, led by Abbvie Inc. at 8.2%, Eli Lilly & Co. at 7.8%, Merck & Company Inc at 5.0%.
JDOC portfolio concentration is moderate, with the top 10 representing 47.5% of total assets. The largest sector exposure is Health Care at 70.3%.
JDOC sectors provide a detailed breakdown. JDOC overlap shows how holdings compare to other funds in your portfolio.
JDOC ETF Holdings
63 of 64 holdings
- 1
Abbvie Inc.
ABBVHealth Care8.20% - 2
Eli Lilly & Co.
LLYHealth Care7.78% - 3
Merck & Company Inc
MRKHealth Care4.96% - 4
Johnson & Johnson - Common
JNJHealth Care4.85% - 5
Thermo Fisherscientific Inc.
TMOHealth Care4.60% - 6
Novartis Ag - Common
NOVN:SMUnknown4.06% - 7
AstraZeneca PLC
AZN:LNUnknown3.95% - 8
Unitedhealth Group Incorporated
UNHHealth Care3.51% - 9
Abbot Laboratories
ABTHealth Care2.89% - 10
Danaher Corporation
DHRHealth Care2.72% - 11
Argenx
ARGX:ASUnknown2.63% - 12
Bristol-Myers Squibb Co.
BMYHealth Care2.60% - 13
Novo Nordisk Class B
NOVOB:COUnknown2.50% - 14
I Q V I A Holdings Inc.
IQVHealth Care2.29% - 15
Cvs Health Corp
CVSHealth Care2.14% - 16
Cencora Inc
CORHealth Care1.99% - 17
Humm Group Ltd
HUM:AUUnknown1.85% - 18
Takeda Pharmaceutical Co. Ltd. Com Stk
4502:JPUnknown1.85% - 19
Biogen Inc. Com
BIIBHealth Care1.84% - 20
Regeneron Pharmaceuticals, Inc.
REGNHealth Care1.77% - 21
Edwards Lifesciences Corp
EWHealth Care1.73% - 22
Roche Ps Par Ag
ROP:SMUnknown1.72% - 23
Bayer Ag
BAYN:SGUnknown1.60% - 24
Teva Pharmaceutical Industries Ltd.
TEVA:ILUnknown1.50% - 25
Nvaesrtex Pharmaceuticals Inc
VRTXHealth Care1.49% - 26
Insmed Inc
INSMHealth Care1.41% - 27
Hoya Corp Common Stock
7741:JPUnknown1.31% - 28
Cardinal Health Inc.
CAHHealth Care1.27% - 29
Sandoz Group Ag
SDZ:SMUnknown1.25% - 30
Charles River Laboratories International Inc
CRLHealth Care1.18% - 31
Genmab A/S
0MGB:COUnknown1.02% - 32
Fresenius Se & Co. Kgaa Germany
FRE:SGUnknown1.01% - 33
Alnylam Pharmaceuticals Inc.
ALNYHealth Care0.95% - 34
Neurocrine Biosciences Inc
NBIXHealth Care0.84% - 35
Centene
CNCHealth Care0.81% - 36
Intuitive Surgical Inc.
ISRGHealth Care0.78% - 37
Biomarin Pharmaceutical Inc.
BMRNHealth Care0.67% - 38
Jpmorgan U.S. Government Money Market Fund, Class IM
MGMXXFinancials0.62% - 39
Spyre Therapeutics Inc
SYREHealth Care0.59% - 40
Bridgebio Pharma Inc_None_0
BBIOHealth Care0.59% - 41
Medtronic Plc Ordinary Shares
MDTHealth Care0.59% - 42
Convatec Group Plc
CTEC:LNUnknown0.57% - 43
Ptc Therapeutics Inc
PTCTHealth Care0.56% - 44
Ascendis Pharma A/S
ASND:COHealth Care0.54% - 45
Boston Scientific Corp.
BSXHealth Care0.53% - 46
Dynegy
DYNHealth Care0.52% - 47
Sartorius Ag Pref
SATG.P:BEUnknown0.51% - 48
Gsk Plc Common Stock Gbp
GSK:LNUnknown0.51% - 49
Cash
Other0.50% - 50
Lb Pharmaceuticals Inc.
LBRXUnknown0.45% - 51
Cg Oncology Inc
CGONHealth Care0.44% - 52
Align Technology Inc.
ALGNHealth Care0.43% - 53
Stryker Corp
SYKHealth Care0.40% - 54
Disc Medicine, Inc.
IRONHealth Care0.35% - 55
LEGEND BIOTECH CORP-ADR
LEGNHealth Care0.34% - 56
APNIMED INC
APMDUnknown0.31% - 57
Erasca Inc.
ERASHealth Care0.31% - 58
Arcus Biosciences Inc
RCUSHealth Care0.30% - 59
Bicara Therapeutics, Inc.
BCAXHealth Care0.30% - 60
Damora Therapeutics, Inc.
DMRAHealth Care0.21% - 61
British Pound
Other0.00% - 62
Euro
Other0.00% - 63
Japanese Yen
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Abbvie Inc. | ABBV | 8.200% | ||
| 2 | Eli Lilly & Co. | LLY | 7.780% | ||
| 3 | Merck & Company Inc | MRK | 4.960% | ||
| 4 | Johnson & Johnson - Common | JNJ | 4.850% | ||
| 5 | Thermo Fisherscientific Inc. | TMO | 4.600% | ||
| 6 | Novartis Ag - Common | NOVN:SM | 4.060% | ||
| 7 | AstraZeneca PLC | AZN:LN | 3.950% | ||
| 8 | Unitedhealth Group Incorporated | UNH | 3.510% | ||
| 9 | Abbot Laboratories | ABT | 2.890% | ||
| 10 | Danaher Corporation | DHR | 2.720% | ||
| 11 | Argenx | ARGX:AS | 2.630% | ||
| 12 | Bristol-Myers Squibb Co. | BMY | 2.600% | ||
| 13 | Novo Nordisk Class B | NOVOB:CO | 2.500% | ||
| 14 | I Q V I A Holdings Inc. | IQV | 2.290% | ||
| 15 | Cvs Health Corp | CVS | 2.140% | ||
| 16 | Cencora Inc | COR | 1.990% | ||
| 17 | Humm Group Ltd | HUM:AU | 1.850% | ||
| 18 | Takeda Pharmaceutical Co. Ltd. Com Stk | 4502:JP | 1.850% | ||
| 19 | Biogen Inc. Com | BIIB | 1.840% | ||
| 20 | Regeneron Pharmaceuticals, Inc. | REGN | 1.770% | ||
| 21 | Edwards Lifesciences Corp | EW | 1.730% | ||
| 22 | Roche Ps Par Ag | ROP:SM | 1.720% | ||
| 23 | Bayer Ag | BAYN:SG | 1.600% | ||
| 24 | Teva Pharmaceutical Industries Ltd. | TEVA:IL | 1.500% | ||
| 25 | Nvaesrtex Pharmaceuticals Inc | VRTX | 1.490% | ||
| 26 | Insmed Inc | INSM | 1.410% | ||
| 27 | Hoya Corp Common Stock | 7741:JP | 1.310% | ||
| 28 | Cardinal Health Inc. | CAH | 1.270% | ||
| 29 | Sandoz Group Ag | SDZ:SM | 1.250% | ||
| 30 | Charles River Laboratories International Inc | CRL | 1.180% | ||
| 31 | Genmab A/S | 0MGB:CO | 1.020% | ||
| 32 | Fresenius Se & Co. Kgaa Germany | FRE:SG | 1.010% | ||
| 33 | Alnylam Pharmaceuticals Inc. | ALNY | 0.950% | ||
| 34 | Neurocrine Biosciences Inc | NBIX | 0.840% | ||
| 35 | Centene | CNC | 0.810% | ||
| 36 | Intuitive Surgical Inc. | ISRG | 0.780% | ||
| 37 | Biomarin Pharmaceutical Inc. | BMRN | 0.670% | ||
| 38 | Jpmorgan U.S. Government Money Market Fund, Class IM | MGMXX | 0.620% | ||
| 39 | Spyre Therapeutics Inc | SYRE | 0.590% | ||
| 40 | Bridgebio Pharma Inc_None_0 | BBIO | 0.590% | ||
| 41 | Medtronic Plc Ordinary Shares | MDT | 0.590% | ||
| 42 | Convatec Group Plc | CTEC:LN | 0.570% | ||
| 43 | Ptc Therapeutics Inc | PTCT | 0.560% | ||
| 44 | Ascendis Pharma A/S | ASND:CO | 0.540% | ||
| 45 | Boston Scientific Corp. | BSX | 0.530% | ||
| 46 | Dynegy | DYN | 0.520% | ||
| 47 | Sartorius Ag Pref | SATG.P:BE | 0.510% | ||
| 48 | Gsk Plc Common Stock Gbp | GSK:LN | 0.510% | ||
| 49 | Cash | - | 0.500% | ||
| 50 | Lb Pharmaceuticals Inc. | LBRX | 0.450% | ||
| 51 | Cg Oncology Inc | CGON | 0.440% | ||
| 52 | Align Technology Inc. | ALGN | 0.430% | ||
| 53 | Stryker Corp | SYK | 0.400% | ||
| 54 | Disc Medicine, Inc. | IRON | 0.350% | ||
| 55 | LEGEND BIOTECH CORP-ADR | LEGN | 0.340% | ||
| 56 | APNIMED INC | APMD | 0.310% | ||
| 57 | Erasca Inc. | ERAS | 0.310% | ||
| 58 | Arcus Biosciences Inc | RCUS | 0.300% | ||
| 59 | Bicara Therapeutics, Inc. | BCAX | 0.300% | ||
| 60 | Damora Therapeutics, Inc. | DMRA | 0.210% | ||
| 61 | British Pound | - | 0.000% | ||
| 62 | Euro | - | 0.000% | ||
| 63 | Japanese Yen | - | 0.000% |




































